Cyclobenzaprine, a centrally-acting muscle relaxant, was first synthesized in 1961 and has been available for human use since 1977. It was initially studied for use as antidepressant given its structural similarity to tricyclic antidepressants - it differs from Amitriptyline by only a single double bond. Since its approval, it has remained relatively popular...
用于缓解与急性疼痛的肌肉骨骼疾病相关的肌肉痉挛(作为休息和物理治疗的辅助药)。但环苯扎林对脑、脊髓疾病或儿童脑性瘫痪引起的痉挛无效。
Prisma Health Midlands, Columbia, South Carolina, United States
Northwestern University, Chicago, Illinois, United States
Ann and Robert H. Lurie Childrens Hospital of Chicago, Chicago, Illinois, United States
Loma Linda University Health, Loma Linda, California, United States
Azidus Brasil Pesquisa Científica e Desenvolvimento Ltda., Valinhos, São Paulo, Brazil
Allegisa, Campinas, São Paulo, Brazil
Tanta university - faculty of medicine, Tanta, Egypt
University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan, United States
Montefiore Medical Center, Bronx, New York, United States
Evanston NorthShore University HealthSystem, Evanston, Illinois, United States
University of Alabama at Birmingham, The Kirklin Clinic, Birmingham, Alabama, United States
Stony Brook University, Stony Brook, New York, United States
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.